Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

4.66
+0.16503.67%
Post-market: 4.63-0.0265-0.57%19:57 EDT
Volume:2.02M
Turnover:9.36M
Market Cap:584.60M
PE:-7.16
High:4.72
Open:4.54
Low:4.52
Close:4.50
52wk High:7.55
52wk Low:2.93
Shares:125.45M
Float Shares:115.00M
Volume Ratio:0.42
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6512
EPS(LYR):-0.7836
ROE:148.50%
ROA:-29.20%
PB:-10.33
PE(LYR):-5.95

Loading ...

Aquestive Therapeutics CEO Daniel Barber Disposes of 25,000 Common Shares Worth $107,168

Reuters
·
Aug 19

ARS Pharmaceuticals Q2 Neffy Revenue Rises as Epinephrine Market Share Doubles

Reuters
·
Aug 14

Analysts’ Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)

TIPRANKS
·
Aug 13

Aquestive Therapeutics (AQST) Stock Faces Cash Burn Questions As Anaphylm Nears Resubmission

Simply Wall St.
·
Aug 13

Aquestive Therapeutics Forecasts 2026 Revenue USD 46 Million-50 Million

Reuters
·
Aug 12

Aquestive Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Aquestive Therapeutics Q2 Revenue Beats on Suboxone Strength

Reuters
·
Aug 12

Aquestive Therapeutics, Inc. Q2 Revenue USD 13.819 Million Vs. IBES Estimate USD 11.4 Million

Reuters
·
Aug 12

Aquestive Therapeutics Inc: Full-Year 2026 Financial Guidance Remains Unchanged

THOMSON REUTERS
·
Aug 12

Aquestive Therapeutics: Confirms That Its Supply Chain Currently Remains Largely Unaffected by Both Implemented & Proposed Government Tariffs

THOMSON REUTERS
·
Aug 12

Aquestive Therapeutics, Inc. Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 12

Aquestive Therapeutics Inc: on Track to Begin Ex-U.S. Filings of Anaphylm in Q4 2026

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Aug 11

Aquestive Therapeutics Shares Rise After Positive Topline Results for Anaphylm Sublingual Film

Dow Jones
·
Aug 10

Aquestive Therapeutics' Potential Allergy Film Shows Improvements in Human Factors Study

MT Newswires Live
·
Aug 10

Aquestive Reports Positive Human Factors, PK Results for Anaphylm Epinephrine Sublingual Film in Healthy Volunteers

Reuters
·
Aug 10

Aquestive Posts Anaphylm Study Presentation on Investor Website

Reuters
·
Aug 10

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (Dibutepinephrine) Sublingual Film

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics - Revised Anaphylm Packaging Reduces Median Pouch Opening Time to 3 Seconds

THOMSON REUTERS
·
Aug 10